Daskivich T - Search Results

1

Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer-A Pilot Study.

Murakami K, Pagano I, Furuya H, Daskivich T, Mori D, Rosser CJ. Murakami K, et al. Among authors: daskivich t. Diagnostics (Basel). 2022 Jan 6;12(1):131. doi: 10.3390/diagnostics12010131. Diagnostics (Basel). 2022. PMID: 35054300 Free PMC article.

2

Use of Bladder Sparing Surgery for Muscle Invasive Bladder Cancer by Life Expectancy at Diagnosis.

Patel DN, Luu M, Zumsteg ZS, Garcia MM, Gupta A, Rosser C, Daskivich TJ. Patel DN, et al. Urol Pract. 2021 Jan;8(1):94-99. doi: 10.1097/UPJ.0000000000000146. Epub 2020 Mar 19. Urol Pract. 2021. PMID: 37145435

3

Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer.

Chamie K, Ballon-Landa E, Daskivich TJ, Bassett JC, Lai J, Hanley JM, Konety BR, Litwin MS, Saigal CS; Urologic Diseases in America Project. Chamie K, et al. Urol Oncol. 2015 Jan;33(1):20.e9-20.e17. doi: 10.1016/j.urolonc.2014.08.016. Epub 2014 Nov 7. Urol Oncol. 2015. PMID: 25443267 Free PMC article.

4

Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link.

Chamie K, Ballon-Landa E, Bassett JC, Daskivich TJ, Leventhal M, Deapen D, Litwin MS. Chamie K, et al. Cancer. 2015 Feb 1;121(3):379-85. doi: 10.1002/cncr.29071. Epub 2014 Oct 22. Cancer. 2015. PMID: 25339141 Free PMC article.

5

Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder.

Patel DN, Luu M, Zumsteg ZS, Daskivich TJ. Patel DN, et al. Eur Urol Oncol. 2019 Nov;2(6):656-663. doi: 10.1016/j.euo.2018.12.012. Epub 2019 Jan 31. Eur Urol Oncol. 2019. PMID: 31412014

6

High-resolution Diffusion-weighted Imaging to Detect Changes in Tumor Size and ADC, and Predict Adverse Biopsy Histology during Prostate Cancer Active Surveillance.

Saouaf R, Xie Y, Kim S, Raphael Y, Nguyen C, Luthringer D, Daskivich TJ, Lo E, Tighiouart M, Li D, Kim HL. Saouaf R, et al. Among authors: daskivich tj. Cancer Res Commun. 2024 Mar 27;4(3):938-945. doi: 10.1158/2767-9764.CRC-24-0009. Cancer Res Commun. 2024. PMID: 38497678 Free PMC article.

7

Recurrence of high-risk bladder cancer: a population-based analysis.

Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, Konety BR, Saigal CS; Urologic Diseases in America Project. Chamie K, et al. Cancer. 2013 Sep 1;119(17):3219-27. doi: 10.1002/cncr.28147. Epub 2013 Jun 4. Cancer. 2013. PMID: 23737352 Free PMC article.

8

External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.

Daskivich TJ, Thomas IC, Luu M, Shelton JB, Makarov DV, Skolarus TA, Leppert JT. Daskivich TJ, et al. J Urol. 2019 Sep;202(3):518-524. doi: 10.1097/JU.0000000000000287. Epub 2019 Aug 8. J Urol. 2019. PMID: 31009286

9

Patient- and tumor-level risk factors for MRI-invisible prostate cancer.

Kuhlmann PK, Chen M, Luu M, Naser-Tavakolian A, Patel DN, Kim HL, Saouaf R, Daskivich TJ. Kuhlmann PK, et al. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):794-801. doi: 10.1038/s41391-021-00330-7. Epub 2021 Feb 10. Prostate Cancer Prostatic Dis. 2021. PMID: 33568751

10

Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.

Daskivich TJ, Luu M, Freedland SJ, Sandler H, Spratt DE, Zumsteg ZS. Daskivich TJ, et al. J Urol. 2022 Mar;207(3):581-591. doi: 10.1097/JU.0000000000002256. Epub 2021 Oct 25. J Urol. 2022. PMID: 34694160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page